Top 15 Diabetes Drugs in 2023 by 2022 Sales Statistics
XTalks
FEBRUARY 8, 2024
for a one-month supply Why it did so well: Jardiance belongs to a class of drugs known as sodium-glucose co-transporter 2 (SGLT2) inhibitors, inhibiting the SGLT2 protein in the kidneys to lead to the excretion of excess glucose through the urine. Jardiance brought in $2.06 billion for Eli Lilly and $6.23 billion for Boehringer Ingelheim.
52 
Let's personalize your content